BanerjeeMPhuljheleSSaxenaR, et al.Impact of weight reduction on structural and functional parameters of the optic nerve in idiopathic intracranial hypertension. Eur J Ophthalmol2024; 34: 1594–1599.
2.
PotterOMenonVMollanSP. Risk factors and disease associations in people living with idiopathic intracranial hypertension. Expert Rev Neurother2024; 24: 681–689.
3.
MollanSPMitchellJLYiangouA, et al.Association of amount of weight lost after bariatric surgery with intracranial pressure in women with idiopathic intracranial hypertension. Neurology2022; 99: e1090–e1099.
4.
MitchellJLLyonsHSWalkerJK, et al.The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain2023; 146: 1821–1830.
5.
QinWYangJNiY, et al.Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: an updated systematic review and meta-analysis including the latest SURMOUNT-2 trial. Endocrine2024; 86: 70–84.
